HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glucocorticoids suppress selected components of the senescence-associated secretory phenotype.

Abstract
Cellular senescence suppresses cancer by arresting the proliferation of cells at risk for malignant transformation. Recently, senescent cells were shown to secrete numerous cytokines, growth factors, and proteases that can alter the tissue microenvironment and may promote age-related pathology. To identify small molecules that suppress the senescence-associated secretory phenotype (SASP), we developed a screening protocol using normal human fibroblasts and a library of compounds that are approved for human use. Among the promising library constituents was the glucocorticoid corticosterone. Both corticosterone and the related glucocorticoid cortisol decreased the production and secretion of selected SASP components, including several pro-inflammatory cytokines. Importantly, the glucocorticoids suppressed the SASP without reverting the tumor suppressive growth arrest and were efficacious whether cells were induced to senesce by ionizing radiation or strong mitogenic signals delivered by oncogenic RAS or MAP kinase kinase 6 overexpression. Suppression of the prototypical SASP component IL-6 required the glucocorticoid receptor, which, in the presence of ligand, inhibited IL-1α signaling and NF-κB transactivation activity. Accordingly, co-treatments combining glucocorticoids with the glucocorticoid antagonist RU-486 or recombinant IL-1α efficiently reestablished NF-κB transcriptional activity and IL-6 secretion. Our findings demonstrate feasibility of screening for compounds that inhibit the effects of senescent cells. They further show that glucocorticoids inhibit selected components of the SASP and suggest that corticosterone and cortisol, two FDA-approved drugs, might exert their effects in part by suppressing senescence-associated inflammation.
AuthorsRemi-Martin Laberge, Lili Zhou, Melissa R Sarantos, Francis Rodier, Adam Freund, Peter L J de Keizer, Su Liu, Marco Demaria, Yu-Sheng Cong, Pankaj Kapahi, Pierre-Yves Desprez, Robert E Hughes, Judith Campisi
JournalAging cell (Aging Cell) Vol. 11 Issue 4 Pg. 569-78 (Aug 2012) ISSN: 1474-9726 [Electronic] England
PMID22404905 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2012 The Authors. Aging Cell © 2012 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland.
Chemical References
  • Glucocorticoids
  • IL6 protein, human
  • Interleukin-1alpha
  • Interleukin-6
  • NF-kappa B
  • Receptors, Glucocorticoid
  • Corticosterone
  • Hydrocortisone
Topics
  • Cell Line
  • Cell Transformation, Neoplastic (drug effects)
  • Cellular Senescence (drug effects, physiology)
  • Corticosterone (pharmacology)
  • Fibroblasts (drug effects, physiology)
  • Glucocorticoids (pharmacology)
  • Humans
  • Hydrocortisone (pharmacology)
  • Interleukin-1alpha (biosynthesis)
  • Interleukin-6 (biosynthesis)
  • NF-kappa B (metabolism)
  • Neoplasm Invasiveness (prevention & control)
  • Phenotype
  • Receptors, Glucocorticoid (metabolism)
  • Signal Transduction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: